Additionally, IGF-1 interacts with factors like platelet-derived growth factor (PDGF) to promote the survival and proliferation of PASMCs, reducing the abnormal pulmonary vascular remodeling caused by cell death and survival imbalance, thereby delaying PAH progression (Jin et al., 2014). The gene discussed is IGF1; the disease is pulmonary arterial hypertension.